The effect of vitamin D on the treatment of gestational diabetes

Not Applicable

• Conditions: Gestational diabetes.; Unspecified diabetes mellitus in pregnancy, childbirth and the puerperium; O24.9

• Registration Number: IRCT20130311012782N34
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

All mothers in the first trimester
Having a risk factor for gestational diabetes (including a previous history of gestational diabetes, high body mass index, diabetes type 2 in the first degree family and a history of macrosomal infant birth)
Having informed consent in a pregnant mother

Exclusion Criteria

Impaired glucose of mothers in the first trimester
Evidence of overt diabetes

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vitamin D Level 3. Timepoint: baseline and 24-28 weeks of gestation. Method of measurement: Serum samples from patients using ELISA method.;Glucose tolerance test. Timepoint: baseline and 24-28 weeks and one time at 35-37 weeks of gestation. Method of measurement: Evaluation of blood glucose in patients at 0, 1, 2, 3 hours after consumption of 100 g glucose.